Evercore ISI Group Maintains Outperform on Medtronic, Raises Price Target to $104
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an 'Outperform' rating on Medtronic and raised its price target from $100 to $104, indicating a positive outlook for the company's stock.
October 01, 2024 | 4:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group has maintained an 'Outperform' rating on Medtronic and raised its price target from $100 to $104, suggesting a positive short-term outlook for the stock.
The 'Outperform' rating and increased price target from a reputable analyst group like Evercore ISI suggest confidence in Medtronic's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100